The Biochemical Basis and Pathophysiology of ADA and PNP Deficiencies
In the majority of inherited disease we are faced with the following situation: we usually know the clinical phenotype — including even its variations — and the mode of inheritance. In many cases, we also have identified the relevant genes and maybe even the mutations in these genes. With the advent of molecular methods in human genetics, knowledge about specific genes and their mutations is rapidly growing. Nonetheless, the relationship between the genotype and the phenotype more often than not is shrouded in complete ignorance. For example in many diseases we do not understand the mechanism leading from the genotype to the phenotype nor do we know anything about the causes of variation within the clinical picture.
KeywordsSine Adenine Creatine Pyrimidine Triphosphate
Unable to display preview. Download preview PDF.
- Brox LW, Pollock E, Belch A (1982) Adenosine and deoxyadenosine toxicity in colony assay systems for human T-lymphocytes, B-lymphocytes, and granulocytes. Cancer Chemother Pharmacol 9: 49Google Scholar
- Burgemeister R, Gutensohn W (1989) Normal ranges of the activities of the different enzymes in 100 independent preparations of chorionic villi. Comparison of specimes from induced abortions, biopsies, and cultured cells. Prenatal Diagnosis 9: 195–204Google Scholar
- Kredich NM and Hershfield MS (1989) Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In: Scriver CM, Beaudet AL, Sly W, Valle D (eds) The metabolic basis of inherited disease, 5th edn. McGraw-Hill, New York, p 1045–1075Google Scholar
- Shore A, Dosch HM, Gelfand EW (1981) Role of adenosine deaminase in the early stages of precursor T cell maturation. Clin exp Immunol 444: 152–155Google Scholar